Mansour Alfayez
Overview
Explore the profile of Mansour Alfayez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
798
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alyamany R, Alnughmush A, Alzahrani H, Alfayez M
Curr Oncol
. 2024 Dec;
31(12):8094-8109.
PMID: 39727719
Chemotherapy-induced cytopenia (CIC) is characterized by neutropenia, anemia, and thrombocytopenia, which are common and serious complications in cancer treatment. These conditions affect approximately 60% of patients undergoing chemotherapy and can...
2.
Aleem A, Shaheen N, Algahtani F, Jamal A, Alkhudair N, Alghafis M, et al.
Clin Lymphoma Myeloma Leuk
. 2024 Sep;
25(1):e50-e56.
PMID: 39299826
Background: Discontinuation of TKI therapy and treatment-free remission (TFR) have become new goals for chronic-phase chronic myeloid leukemia (CP-CML). The aim of this study was to estimate the TFR post...
3.
Alyamany R, Albachir C, Alsaleh S, Hamad A, Abdulwali S, Alotaibi A, et al.
J Hematol
. 2024 Jul;
13(3):128-136.
PMID: 38993735
Systemic mastocytosis (SM) is a rare type of myeloproliferative neoplasm characterized by abnormal proliferation and infiltration of different tissue by clonal mast cells. The uncontrolled proliferation and activation of mast...
4.
Alyamany R, Alnughmush A, Almutlaq M, Alyamany M, Alfayez M
Front Oncol
. 2024 Feb;
14:1345492.
PMID: 38406809
Azacitidine, a hypomethylating agent, has caused a paradigm shift in the outcomes of patients with myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) who are not eligible for stem cell...
5.
Root J, Desai P, Ly C, Wang B, Jelloul F, Zhou J, et al.
Cancer Res Commun
. 2024 Feb;
4(3):671-681.
PMID: 38391202
Significance: We found T-cell polyfunctionality differs between local and systemic microenvironments. Enhanced variability in proteomic profiles of bone marrow CD4 T cells post-IO suggests their pivotal role in AML treatment...
6.
El Fakih R, Nassani M, Rasheed W, Hanbali A, Almohareb F, Chaudhri N, et al.
Transplant Cell Ther
. 2024 Jan;
30(3):312.e1-312.e7.
PMID: 38185379
Haploidentical donor (haplo-) hematopoietic stem cell transplantation (HSCT) with post-transplantation cyclophosphamide (PTCy) is now performed on a large scale worldwide. Our patient outcomes did not completely reflect the results published...
7.
Hameed M, Bakshi N, Alfayez M
JAMA Oncol
. 2023 Oct;
10(1):129-130.
PMID: 37856102
No abstract available.
8.
Kotb A, Alzahrani H, Alahmari A, Ahmed S, Alhayli S, Shaheen M, et al.
Cytotherapy
. 2023 Sep;
25(12):1331-1337.
PMID: 37737766
Background Aims: Graft failure after allogeneic transplant for aplastic anemia is problematic. The risk of graft failure depends on multiple variables, including the preparative regimen, donor type, stem cell dose...
9.
Aldawood Z, Bin Morya M, Alrajhi A, Alfayez M, Alswayyed A, AlShehry N
Hematology
. 2023 Aug;
28(1):2252649.
PMID: 37642434
No abstract available.
10.
Figueroa M, Ma H, Alfayez M, Morales-Mantilla D, Wang F, Lu Y, et al.
Blood Adv
. 2023 Jul;
7(21):6624-6629.
PMID: 37486624
No abstract available.